# TUM Klinikum rechts der Isar / CCC München

Source: https://onco.cc/institutions/tum-munich/  
OnCo record `tum-munich` (Institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Munich's technical university hospital, one half of the Comprehensive Cancer Center Munich and a leader in PSMA imaging and radiopharmaceutical chemistry.

## Summary

The Klinikum rechts der Isar is the university hospital of the Technical University of Munich and, with the LMU, forms the CCC München, a German Cancer Aid Oncology Center of Excellence and DKTK partner site. Its nuclear medicine and radiopharmacy groups developed the radiohybrid PSMA ligands (rhPSMA) that became flotufolastat F-18, and run large theranostic programmes in prostate and neuroendocrine cancer. The TranslaTUM centre houses translational oncology, imaging and immunology, and the hospital has strong pancreatic surgery, haematology and gastrointestinal oncology programmes. Patients access molecular tumour boards and early-phase trials across both Munich university sites.

## Fields

- Kind: Institution
- Last checked: 2026-09-09
- Also known as: Klinikum rechts der Isar; Technical University of Munich; Comprehensive Cancer Center Munich (TUM)
- City: Munich, DE
- Type: university
- Website: https://www.mri.tum.de

## Sources

- Homepage: https://www.mri.tum.de
- CCC München: https://www.ccc-muenchen.de
- TranslaTUM: https://www.translatum.tum.de

## Connected records

- cancers: [Colorectal cancer](https://onco.cc/cancers/colorectal/), [Neuroendocrine tumours](https://onco.cc/cancers/neuroendocrine/), [Pancreatic ductal adenocarcinoma](https://onco.cc/cancers/pancreatic/), [Prostate cancer](https://onco.cc/cancers/prostate/)
- fronts: [Imaging](https://onco.cc/fronts/imaging/), [Radiopharmaceuticals & Theranostics](https://onco.cc/fronts/radiopharma/)
- technologies: [FAPI PET](https://onco.cc/technologies/fapi-pet/), [MR-guided adaptive radiotherapy](https://onco.cc/technologies/mr-linac/), [PET/MRI](https://onco.cc/technologies/pet-mri/), [PSMA PET](https://onco.cc/technologies/psma-pet/), [Radioligand therapy (beta emitters)](https://onco.cc/technologies/radioligand-therapy/)
- drugs: [Lutetium-177 dotatate](https://onco.cc/drugs/lutathera/), [Lutetium-177 vipivotide tetraxetan](https://onco.cc/drugs/pluvicto/)
- institutions: [German Cancer Consortium (DKTK)](https://onco.cc/institutions/dktk/), [German Cancer Research Center (DKFZ)](https://onco.cc/institutions/dkfz/), [LMU Klinikum München](https://onco.cc/institutions/lmu-munich/)
- terms: [Theranostics](https://onco.cc/terms/theranostics/)
- people: [Martin Siess](https://onco.cc/people/martin-siess/), [Wolfgang A. Weber](https://onco.cc/people/wolfgang-weber/)

---
JSON: https://onco.cc/api/v1/entities/tum-munich.json